LOGM 51.72 Logmein Inc $LOGM Hit a 52 week high of 51.93

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 1:21 PM

LOGM 51.72 Logmein Inc $LOGM Hit a 52 week high of 51.93 Closing the day 09:43 at 51.72 -0.09 -0.17% With a day low of 51.53 and a total volume of 19,609.

LOGM Recent Posts: http://investorshangout.com/LogMeIn-Inc-LOGM-54654/

LOGM Logmein Inc Recent Headline News

LogMeIn Shares Up 14.3% Since SmarTrend's Buy Recommendation (LOGM)
Comtex SmarTrend(R) - 2 hrs 55 mins ago
SmarTrend identified an Uptrend for LogMeIn (NASDAQ:LOGM) on September 11th, 2014 at $45.37. In approximately 2 months, LogMeIn has returned 14.34% as of today's recent price of $51.87.
LOGM: 51.61 (-0.20)

King Digital Entertainment (KING) Jumps: Stock Rises 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:57AM CST
King Digital Entertainment plc (KING) was a big mover last session, as the company saw its shares rise over 7% on the day.
DHX: 11.28 (-0.03), DTSI: 32.82 (+0.01), LOGM: 51.61 (-0.20), KING: 15.64 (+0.59)

Can The Uptrend Continue for LogMeIn (LOGM)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:14AM CST
Can The Uptrend Continue for LogMeIn (LOGM)?
LOGM: 51.61 (-0.20)

CACI International Secures $32.5M US Army Contract - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:07PM CST
CACI International Inc (CACI) recently secured a $32.5 million contract to support the development of sensor technologies for the U.S. Army???s Night Vision and Electronic Sensors Directorate (NVESD).
CARB: 11.61 (+0.13), LOGM: 51.61 (-0.20), CACI: 85.86 (-0.46), NCIT: 10.92 (+0.28)

CACI, JIEDDO Team Up to Counter Improvised Explosives - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 5:30PM CST
CACI International (CACI) secured a task order potentially worth $149 million, under which it will deploy operations/intelligence integration teams to aid U.S. Defense in combating improvised explosive devices.
CARB: 11.61 (+0.13), LOGM: 51.61 (-0.20), CACI: 85.86 (-0.46), NCIT: 10.92 (+0.28)

LogMeIn to Underscore Importance of Mobile Customer Engagement at Contact Center Demo & Conference
GlobeNewswire - Wed Nov 05, 8:08AM CST
LogMeIn, Inc.'s (Nasdaq:LOGM) Ross Haskell will be a featured speaker at this week's Contact Center Demo & Conference, taking place at the Hyatt Regency Chicago from Nov. 5-7, 2014. Haskell--who leads product strategy for BoldChat, LogMeIn's live chat and multichannel customer engagement offering--will co-present a session titled, "When it Comes to Customer Engagement - Mobile Changes EVERYTHING" taking place today at 3:45 pm CST.
LOGM: 51.61 (-0.20)

CACI International Hits 52-Week High on Strong Q1 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 4:20PM CST
Shares of CACI International (CACI) hit a 52-week high of $84.08 on Nov 3, 2014. However, the stock closed the session at $83.69, which reflects a solid year-to-date return of 14.6%.
CARB: 11.61 (+0.13), LOGM: 51.61 (-0.20), CACI: 85.86 (-0.46), NCIT: 10.92 (+0.28)

LogMeIn to Discuss How to Create Connected Products that Transform Customer Engagement at Internet of @Things Expo
GlobeNewswire - Mon Nov 03, 8:35AM CST
LogMeIn's (Nasdaq:LOGM) Sean Lorenz, Technical Product Manager for the Xively IoT Platform, will be a featured speaker at Internet of @Things Expo, taking place November 4 - 6, 2014 in Santa Clara, California.
LOGM: 51.61 (-0.20)

CACI Comfortably Beats Q1 Earnings, Maintains FY15 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 11:10AM CDT
CACI International Inc (CACI) reported adjusted earnings of $43.6 million or $1.81 per share in the first quarter of fiscal 2015 versus $44.7 million or $1.80 per share in the prior-year quarter.
CSGS: 25.79 (-0.03), LOGM: 51.61 (-0.20), CACI: 85.86 (-0.46), INOD: 2.60 (unch)

Update: LogMeIn Tops Earnings Again For Q3
Marshall Hargrave - at Seeking Alpha - Thu Oct 30, 9:04AM CDT

LOGM: 51.61 (-0.20)

LogMeIn (LOGM) Upgraded From Hold to Buy
at The Street - Thu Oct 30, 8:39AM CDT
LogMeIn (LOGM) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
LOGM: 51.61 (-0.20)

SATO picks LogMeIn to enable IoT-connected printers
M2 - Thu Oct 30, 7:37AM CDT
LogMeIn (NASDAQ: LOGM) said that SATO has selected LogMeIn's Xively Internet of Things platform to build next-generation connectivity into its printers.
LOGM: 51.61 (-0.20)

SATO Selects LogMeIn to Enable Its Next Generation of IoT-Connected Printers
GlobeNewswire - Wed Oct 29, 8:00AM CDT
LogMeIn (Nasdaq:LOGM) today announced that SATO has selected LogMeIn's Xively Internet of Things (IoT) platform to build next-generation connectivity into its printers. SATO, a global provider of barcode printing, labeling, and EPC/RFID solutions, is also working with LogMeIn's IoT experts to maximize the business value of its IoT-connected products and accelerate their time to market. As a result, SATO anticipates a faster introduction of connected customer experiences across market segments, further differentiating its printer solutions against competitors, and lowering operational and support costs for its customers.
LOGM: 51.61 (-0.20)

LogMeIn's Strong Third Quarter Supports Bullish Long-Term View
Chris Katje - at Seeking Alpha - Mon Oct 27, 2:26PM CDT

LOGM: 51.61 (-0.20)

LogMeIn CMO, W. Sean Ford, to Participate in "Rise of the Empowered Customer" Roundtable Event
GlobeNewswire - Mon Oct 27, 8:00AM CDT
W. Sean Ford, Chief Marketing Officer of LogMeIn, Inc., (Nasdaq:LOGM) will be a featured speaker at the PAN Communications roundtable event, "Rise of the Empowered Customer," taking place on October 28, 2014 at the PAN Communications office. He will join a panel of leading marketing executives to discuss how they are positioning their organizations for success in a world driven by behavioral analytics that impact brands.
LOGM: 51.61 (-0.20)

LogMeIn reports Q3 2014 revenue up 35 percent YoY
M2 - Mon Oct 27, 6:26AM CDT
LogMeIn, Inc. (NASDAQ: LOGM) said its total third quarter 2014 revenue increased 35 percent to USD58.1 million from USD43.0 million reported in the third quarter of 2013.
LOGM: 51.61 (-0.20)

LogMeIn Named 2014 Boston Preservation Achievement Award Winner
GlobeNewswire - Fri Oct 24, 8:00AM CDT
LogMeIn, Inc. (Nasdaq:LOGM), has been named a winner of the 2014 Boston Preservation Achievement Awardsin recognition for the company's renovation and restoration of its corporate headquarters located at 320 Summer Street in Boston's Innovation District. The company's project was also voted the fan favorite 2014 Preservation Achievement Award winner by an online public vote.
LOGM: 51.61 (-0.20)

LogMeIn Q3 2014 revenue up 35% YoY
M2 - Fri Oct 24, 6:11AM CDT
LogMeIn, Inc. (NASDAQ: LOGM) said its total third quarter 2014 revenue increased 35 percent to $58.1 million from $43.0 million reported in the third quarter of 2013.
LOGM: 51.61 (-0.20)

LogMeIn Reports Third Quarter Results
Business Wire - Fri Oct 24, 5:00AM CDT
LogMeIn, Inc. (NASDAQ: LOGM) announced its results for the third quarter of 2014. Total revenue increased 35 percent to $58.1 million from $43.0 million reported in the third quarter of 2013.
LOGM: 51.61 (-0.20)

LogMeIn's (LOGM) CEO Michael Simon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 7:55PM CDT

LOGM: 51.61 (-0.20)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...